Jóźwiak-Bębenista, M.; Sokołowska, P.; Siatkowska, M.; Panek, C.A.; Komorowski, P.; Kowalczyk, E.; Wiktorowska-Owczarek, A.
The Importance of Endoplasmic Reticulum Stress as a Novel Antidepressant Drug Target and Its Potential Impact on CNS Disorders. Pharmaceutics 2022, 14, 846.
https://doi.org/10.3390/pharmaceutics14040846
AMA Style
Jóźwiak-Bębenista M, Sokołowska P, Siatkowska M, Panek CA, Komorowski P, Kowalczyk E, Wiktorowska-Owczarek A.
The Importance of Endoplasmic Reticulum Stress as a Novel Antidepressant Drug Target and Its Potential Impact on CNS Disorders. Pharmaceutics. 2022; 14(4):846.
https://doi.org/10.3390/pharmaceutics14040846
Chicago/Turabian Style
Jóźwiak-Bębenista, Marta, Paulina Sokołowska, Małgorzata Siatkowska, Cecilia Analia Panek, Piotr Komorowski, Edward Kowalczyk, and Anna Wiktorowska-Owczarek.
2022. "The Importance of Endoplasmic Reticulum Stress as a Novel Antidepressant Drug Target and Its Potential Impact on CNS Disorders" Pharmaceutics 14, no. 4: 846.
https://doi.org/10.3390/pharmaceutics14040846
APA Style
Jóźwiak-Bębenista, M., Sokołowska, P., Siatkowska, M., Panek, C. A., Komorowski, P., Kowalczyk, E., & Wiktorowska-Owczarek, A.
(2022). The Importance of Endoplasmic Reticulum Stress as a Novel Antidepressant Drug Target and Its Potential Impact on CNS Disorders. Pharmaceutics, 14(4), 846.
https://doi.org/10.3390/pharmaceutics14040846